Le Lézard
Classified in: Health
Subject: PDT

Convergent Dental announces commercial availability of Solea® Protecttm to strengthen dental enamel using the Solea® All-Tissue Dental Laser


Studies have shown that using Solea Protect in conjunction with fluoride is up to six times more effective at reducing mineral loss in tooth enamel than fluoride alone.

WALTHAM, Mass., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Tooth decay, also known as dental caries, can affect patients of all ages and is one of the top reasons for dental appointments. Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, is now helping dentists inhibit caries development with the commercial launch of Solea® Protecttm. This new application for the Solea laser helps reduce mineral loss in dental enamel, protecting teeth against acid attack and caries development.

Preventing tooth decay benefits nearly everyone and Solea Protect gives providers easy-to-use technology that is convenient and effective for their patients. This new application is another example of the Solea laser's versatility and how Convergent Dental is pushing the future of dentistry forward.

Solea Protect is the result of decades of research in caries prevention using CO2 lasers. The treatment uses the Solea laser's novel 9.3-micron wavelength to gently heat the surface of tooth enamel, removing impurities that can weaken teeth. This process creates a strong, crystal-like tooth structure that is more resistant to decay (click here for the animation). When used in combination with fluoride, Solea Protect reduces mineral loss up to six times more than fluoride alone.[1] In a one-year clinical trial, 22% of patients who received only fluoride treatments required a caries restoration within the 12 months. Conversely, none of the patients (0%) who were treated with a combination of Solea Protect and fluoride required a restoration during the trial.[2]

"Convergent Dental is committed to driving innovation that elevates dental practices. Preventing tooth decay benefits nearly everyone and Solea Protect gives providers easy-to-use technology that is convenient and effective for their patients," said Robert L. Gershon, CEO of Convergent Dental. "This new application is another example of the versatility of the Solea laser and how Convergent Dental is pushing the future of dentistry forward."

With the addition of the Solea Protect treatment, the Solea laser enables dentists to offer both a unique preventative treatment and an anxiety-free experience when restorative work is required.

About Convergent Dental

Convergent Dental, Inc. (www.convergentdental.com) is a privately owned dental equipment and technology company. The Company's flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists can rely on.[3] Solea is a true breakthrough in dental laser technology that offers a completely different experience for both dentists and patients when compared to traditional instruments or any earlier laser treatment. Solea enables dentists to elevate their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.[4]

For more information, please visit www.convergentdental.com. Follow the company on Instagram, Facebook and LinkedIn.

[1] Badreddine AH, et al. Demineralization Inhibition by High-Speed Scanning of 9.3 ?m CO2 Single Laser Pulses Over Enamel. Lasers Surg Med. 2021 Jul;53(5):703-712.

[2] Rechmann P, et al. Fissure caries inhibition with a CO2 9.3-?m short-pulsed laser-a randomized, single-blind, split-mouth controlled, 1-year clinical trial. Clin Oral Investig. 2021 Apr;25(4):2055-2068.

[3] Based on report of 1000 procedures performed by Solea users. Documentation on file.

[4] Based on 2022 Annual Survey of Solea users. Documentation on file.

Media Contact

Caitlin D'Entremont, Convergent Dental, 1 5085005656, [email protected], https://www.convergentdental.com/

Twitter, LinkedIn

SOURCE Convergent Dental


These press releases may also interest you

at 09:47
USANA Health Sciences, Inc. applauds Donald Cherry, executive director of corporate sustainability and DEI, for being named a 40 Under 40 award winner by Utah Business magazine....

at 09:45
The Prostate Cancer Foundation (PCF) and the American Cancer Society (ACS) today announced the ACS-PCF Young Investigator Award totaling $225,000 over three years to support a novel health equity research project that aims to reduce disparities in...

at 09:37
MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce the hiring of FDA Mathematical Statistician for Diagnostic Devices, Chava Zibman,...

at 09:35
In the news release, Planet Fitness, Inc. Announces Fourth Quarter and Year-End 2023 Results, issued 22-Feb-2024 by Planet Fitness, Inc. over PR Newswire, we are advised by the company that the second bullet in the 2024 Outlook section should read...

at 09:32
TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company")  a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that the MHRA has officially accepted...

at 09:30
Today, the Foundation for Advancing Family Medicine (FAFM) of the College of Family Physicians of Canada (CFPC) kicks off the first day of the two-day Team Primary Care (TPC) Summit at the Shaw Centre in Ottawa. This event brings together Canada's...



News published on and distributed by: